Research

Genetic Component of Alzheimer’s Disease

DNA

By Lumos Labs Science Associate, Paul Li, MS Neuroscience.

There is some new evidence that Alzheimer’s disease is much more likely for people whose parents both have the neurodegenerative disorder than if only one parent has it. Researchers examined families in which both parents have Alzheimer’s, and found that their children ended up with the disease 42% of the time.


The War on Animal Research

Vandalism

What it's like to be hounded by activists who will stop at nothing to stop your research.

By P. Michael Conn, The-Scientist.com
Photographs by Bill Cramer

This is an edited excerpt from The Animal Research War by P. Michael Conn and James V. Parker, to be published by Palgrave Macmillan in May 2008.

For more information please visit www.palgrave-usa.com.

"Excuse me," I said, cutting to the front of the line of passengers at the airport departure gate counter. "I have an emergency and need you to call the police right now!" Two airline agents stopped checking seating charts and looked at me. "I am a medical researcher and some people are protesting my visit to Tampa. They're not passengers," I explained. (This was in 2001, shortly before 9/11, when security measures allowed nonpassengers into boarding areas.)

One desk agent examined my boarding pass, and then looked at my pursuers. I knew what she saw: five people with T-shirts that read: "KEEP PRIMATE TESTER Dr. P.M. CONN OUT OF U.S.F." She let me through. Ten minutes later, when the pilot boarded and asked if I was okay, and I heard the outer doors close, my blood pressure and heart rate slowly began to sink into normal ranges.


Prescription Drug User Fee Act (PDUFA) IV Drug Safety Five-Year Plan

FDA

1.0 INTRODUCTION

The Prescription Drug User Fee Act (PDUFA) enacted in 1992 provided authority for FDA to collect additional resources (fees from industry) and enable FDA to accelerate its drug evaluation process without compromising review quality. Since 1992 PDUFA has seen a progression of performance commitments designed to speed drug development and approval while preserving and even raising FDA’s high standards for safety, effectiveness, and product quality. Congress reauthorized PDUFA in 1997 under the FDA Modernization Act (FDAMA) and again in 2002 under the Public Health Security and Bioterrorism Preparedness and Response Act. Most recently Congress reauthorized PDUFA for another five years under the Food and Drug Administration Amendments Act of 2007 (FDAAA).


Advances in Synthetic Chemistry

04/08/2008 - 14:00
04/09/2008 - 14:59

Welcome to Advances in Synthetic Chemistry, our first conference devoted to advances in synthesis techniques and technologies.

Set in the historic and easily accessible city of Frankfurt, the meeting will focus primarily on Flow Chemistry and Microwave-Assisted Organic Synthesis.

For further information please visit the official website.


A Free, Online Global Network of Doctors and Researchers in Life Sciences

Medical Staff

Prometheus, in Greek mythology was the god who formed humans from clay. He then stole the fire from Zeus, and gave it to men. For this, he was chained on Mount Caucaso and condemned to be forever eaten by an eagle. He was then set free by Hercules, and returned to Olympus with the approval of Zeus.

As of introducer of fire and inventor of crafts, having brought knowledge to men, Prometheus was seen as the patron of human civilization. PrometeoNetwork decided to name itself after this mythological figure, hoping to bring more knowledge to its members.


COVERONE A Leading Newsletter Reporting On Latest Reimbursement Trends

RADical Group
  • Medicare and Medicaid Spending for Specialty Pharmacy
  • Shifting of Biologic and Injectable Costs from the Medical to the Pharmacy Budgets
  • Reimbursement Checklist of Questions every emerging biotech company should answer for business planning
  • Demonstrating your products "value" proposition to Formulary Decision Makers
  • Finding your price point when launching a product to government and commercial health plans
  • DOWNLOAD ATTACHED .PDF BELOW TO READ NEWSLETTER

    For questions or information contact rgreenapple@radicalgrp.com
    Published by RADical Group


    EdgeWater Research Partners A Subscription Based Independent Research Company

    Edgewater Research

    EdgeWater Research Partners LLC (“EdgeWater”) is a subscription based independent research company focused on micro cap and small cap issuers for which little or no industry research is available. The Company publishes a monthly newsletter titled the “EdgeWater Micro Monthly”, as well as individual initial coverage research and periodic updates on relatively undiscovered public companies. The research is “generalist” in nature and therefore includes a rather eclectic mix of companies at any given point in time.


    Syndicate content